The plasma lipidome varies with the severity of metabolic dysfunction-associated steatotic liver disease
Clément J. F. Heymann(Amsterdam University Medical Centers), Aldo Grefhorst(Amsterdam Neuroscience), Maarten E. Tushuizen(Leiden University Medical Center), Ger H. Koek(Maastricht University Medical Centre), Joanne Verheij, Adriaan G. Holleboom(Amsterdam University Medical Centers), Ronit Shiri‐Sverdlov(Maastricht University), Anne Linde Mak(Amsterdam University Medical Centers), Saskia W. C. van Mil(Unknown)
Cited by 7
Related Papers
Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates
|Proceedings of the National Academy of Sciences|2008|641
Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trial
|The Lancet. Gastroenterology & hepatology|2019|597
The Ins and Outs of Cathepsins: Physiological Function and Role in Disease Management
|Cells|2020|538
Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis†
|Hepatology|2008|467
Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibrates
|Journal of Hepatology|2005|241